{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:42:22Z","timestamp":1784252542177,"version":"3.55.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2019 \u5e749062"],"award-info":[{"award-number":["2019 \u5e749062"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>This study aimed to investigate the effects of PAItrap3, a novel PAI-1 inhibitor, on lipid metabolism, and autophagy pathways in diabetic mice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>db\/db diabetic mice were administered PAItrap3 (5.7\u00a0mg\/kg\/day, IV) for 21 consecutive days, and its impact on metabolic, gene expression, and lipidomic profiles was assessed. Western blot analysis was performed to examine lipid metabolism-related proteins in white adipose tissue (FASN, HSL, CPT1A, ACADM) and autophagy markers (LC3B, P62, Parkin, PGC1\u03b1, PPARGC1B). Additionally, RNA-seq and targeted lipidomics were employed to analyze gene expression and lipid metabolic alterations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>PAItrap3 significantly reduced blood glucose and glycated hemoglobin levels while improving insulin sensitivity. In lipid metabolism, FASN and HSL levels were upregulated, whereas CPT1A and ACADM levels were downregulated in the DMP group. Regarding the autophagy pathway, PPARGC1B, LC3B, and PGC1\u03b1 expression levels were increased, while P62 and Parkin levels were decreased. Lipidomics analysis revealed that triglycerides (TG) and diacylglycerols (DG) were generally downregulated, with TG (18:2\/18:2\/18:2) (0.96 [0.8491, 1]), LPI (18:0) (0.96 [0.8491, 1]), and MLCL (14:3\/20:4\/22:6) (0.96 [0.8491, 1]) identified as key metabolites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study finds that PAItrap3 modulates lipid metabolism, energy homeostasis, and autophagy pathways, thereby improving metabolic dysfunction in diabetic mice. These findings highlight its potential therapeutic value for treating diabetes-associated lipid metabolic disorders.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1596655","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:11:09Z","timestamp":1749701469000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanistic insights into the PAI-1 inhibitor PAItrap3: enhancing lipid metabolism in adipose tissue of diabetic db\/db mice"],"prefix":"10.3389","volume":"16","author":[{"given":"Linxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouyangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.3390\/ijms22063170","article-title":"PAI-1 in diabetes: pathophysiology and role as a therapeutic target","volume":"22","author":"Altalhi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2337\/dc24-S008","article-title":"Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of Care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","article-title":"Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle","volume":"1","author":"Arany","year":"2005","journal-title":"Cell metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/metabo6010006","article-title":"Lysophosphatidylinositol signalling and metabolic diseases","volume":"6","author":"Arifin","year":"2016","journal-title":"Metabolites"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101494","DOI":"10.1016\/j.molmet.2022.101494","article-title":"Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis","volume":"61","author":"Asif","year":"2022","journal-title":"Mol. Metab."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.22783","article-title":"V PAI-1 in tissue fibrosis","volume":"227","author":"Asish","year":"2011","journal-title":"J. Cell Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1152\/ajpendo.00273.2022","article-title":"Decreased adiponectin\/leptin ratio relates to insulin resistance in adults with obesity","volume":"324","author":"Castela","year":"2023","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1002\/imt2.217","article-title":"Majorbio Cloud 2024: update single-cell and multiomics workflows","volume":"3","author":"Chang","year":"2024","journal-title":"Imeta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.thromres.2012.06.023","article-title":"The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo","volume":"130","author":"De Craen","year":"2012","journal-title":"Thromb. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"167666","DOI":"10.1016\/j.bbadis.2025.167666","article-title":"Unlocking the therapeutic potential of canagliflozin in NAFLD: insights into AMPK\/SIRT1-mediated lipophagy","volume":"1871","author":"El-Ashmawy","year":"2025","journal-title":"Biochimica biophysica acta. Mol. basis Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.1021\/acs.jafc.3c09601","article-title":"Puerarin induces macrophage M2 polarization to exert antinonalcoholic steatohepatitis pharmacological activity via the activation of autophagy","volume":"72","author":"Fang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s10753-011-9397-2","article-title":"The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome","volume":"35","author":"Flavia Campos","year":"2011","journal-title":"Inflammation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8838","DOI":"10.3390\/ijms24108838","article-title":"Polyunsaturated fatty acids: conversion to lipid mediators, roles in inflammatory diseases and dietary sources","volume":"24","author":"Harwood","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12967-024-05274-9","article-title":"Lipidomic studies revealing serological markers associated with the occurrence of retinopathy in type 2 diabetes","volume":"22","author":"He","year":"2024","journal-title":"J. Transl. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/j.gastro.2006.02.006","article-title":"Targeted deletion of FATP5 reveals multiple functions in liver metabolism: alterations in hepatic lipid homeostasis","volume":"130","author":"Holger","year":"2006","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112588","article-title":"K polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review","volume":"11","author":"Karen","year":"2019","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MOL.0000000000000789","article-title":"ANGPTL3 as therapeutic target","volume":"32","author":"Kersten","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/ATVBAHA.119.313775","article-title":"Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome","volume":"40","author":"Khoukaz","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"103651","DOI":"10.1016\/j.autrev.2024.103651","article-title":"Association between Omega-3 fatty acids and autoimmune disease: evidence from the umbrella review and Mendelian randomization analysis","volume":"23","author":"Kimsor","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.7150\/ijbs.44774","article-title":"Bile acids mediated potential functional interaction between FXR and FATP5 in the regulation of Lipid Metabolism","volume":"16","author":"Kumari","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s10495-009-0352-8","article-title":"Diabetes and apoptosis: lipotoxicity","volume":"14","author":"Kusminski","year":"2009","journal-title":"Apoptosis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"89746","DOI":"10.18632\/oncotarget.21120","article-title":"TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease","volume":"8","author":"Lee","year":"2017","journal-title":"Oncotarget"},{"key":"B26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","article-title":"Role of PAI-1 in hepatic steatosis and dyslipidemia","volume":"11","author":"Levine","year":"","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/oby.23112","article-title":"Inhibition of PAI-1 promotes lipolysis and enhances weight loss in obese mice","volume":"29","author":"Levine","year":"","journal-title":"Obes. (Silver Spring)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1055\/s-0031-1277226","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes","volume":"43","author":"Li","year":"2011","journal-title":"Horm. Metab. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"116906","DOI":"10.1016\/j.bcp.2025.116906","article-title":"Effect of PAI-1 inhibitor on pancreatic islet function and hepatic insulin resistance in db\/db mice","volume":"237","author":"Lin","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"111663","DOI":"10.1016\/j.cellsig.2025.111663","article-title":"WIPI1-mediated mitophagy dysfunction in ventricular remodeling associated with long-term diabetes mellitus","volume":"130","author":"Liu","year":"2025","journal-title":"Cell. Signal."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1056186","DOI":"10.3389\/fgene.2023.1056186","article-title":"Polymorphism in genes encoding two fatty acid binding proteins increases risk of ischemic stroke in a Chinese Han population","volume":"14","author":"Maolin","year":"2023","journal-title":"Front. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.3390\/nu15143129","article-title":"Linoleic acid: a narrative review of the effects of increased intake in the standard American diet and associations with chronic disease","volume":"15","author":"Mercola","year":"2023","journal-title":"Nutrients"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbabio.2007.07.011","article-title":"Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin","volume":"1767","author":"Petrosillo","year":"2007","journal-title":"Biochimica biophysica acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100680","DOI":"10.1016\/j.jlr.2024.100680","article-title":"ACAT1\/SOAT1 maintains adipogenic ability in preadipocytes by regulating cholesterol homeostasis","volume":"65","author":"Qing","year":"2024","journal-title":"J. Lipid Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116060","article-title":"6-Gingerol regulates triglyceride and cholesterol biosynthesis to improve hepatic steatosis in MAFLD by activating the AMPK-SREBPs signaling pathway","volume":"170","author":"Qingsong","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"578966","DOI":"10.3389\/fphys.2020.578966","article-title":"Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases","volume":"11","author":"Recinella","year":"2020","journal-title":"Front. Physiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"622473","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front. Cardiovasc Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nature07976","article-title":"Autophagy regulates lipid metabolism","volume":"458","author":"Singh","year":"2009","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.3390\/ijms25137358","article-title":"GPR55 antagonist CID16020046 attenuates obesity-induced airway inflammation by suppressing chronic low-grade inflammation in the lungs","volume":"25","author":"Son","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coph.2005.01.007","article-title":"Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease","volume":"5","author":"Taeye","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"117404","DOI":"10.1016\/j.lfs.2020.117404","article-title":"Specific inhibition of plasminogen activator inhibitor 1 reduces blood glucose level by lowering TNF-a","volume":"246","author":"Tang","year":"2020","journal-title":"Life Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.3390\/biom13121692","article-title":"Adipokines and bacterial metabolites: a pivotal molecular bridge linking obesity and gut microbiota dysbiosis to target","volume":"13","author":"Turpin","year":"2023","journal-title":"Biomolecules"},{"key":"B43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/ajh\/hpab138","article-title":"Plasminogen activator inhibitor-1 and adiponectin are associated with metabolic syndrome components","volume":"35","author":"Vecchiola","year":"2022","journal-title":"Am. J. Hypertens."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3390\/metabo13111121","article-title":"GLP-1 receptor agonist improves mitochondrial energy status and attenuates nephrotoxicity in vivo and in vitro","volume":"13","author":"Wang","year":"2023","journal-title":"Metabolites"},{"key":"B45","doi-asserted-by":"publisher","first-page":"e2304408","DOI":"10.1002\/advs.202304408","article-title":"Loss of SLC27A5 activates hepatic stellate cells and promotes liver fibrosis via unconjugated cholic acid","volume":"11","author":"Wu","year":"","journal-title":"Adv. Sci. Weinheim, Baden-Wurttemberg, Ger."},{"key":"B46","doi-asserted-by":"publisher","first-page":"103183","DOI":"10.1016\/j.redox.2024.103183","article-title":"Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 dependent osteogenic reprogramming","volume":"73","author":"Wu","year":"","journal-title":"Redox Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41467-023-44559-3","article-title":"ApoL6 associates with lipid droplets and disrupts Perilipin1-HSL interaction to inhibit lipolysis","volume":"15","author":"Yuhui","year":"2024","journal-title":"Nat. Commun."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e26326","DOI":"10.1016\/j.heliyon.2024.e26326","article-title":"Lipidomics based on UHPLC\/Q-TOF-MS to characterize lipid metabolic profiling in patients with newly diagnosed type 2 diabetes mellitus with dyslipidemia","volume":"10","author":"Zhong","year":"2024","journal-title":"Heliyon"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1596655\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:11:10Z","timestamp":1749701470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1596655\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":48,"alternative-id":["10.3389\/fphar.2025.1596655"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1596655","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"article-number":"1596655"}}